GOLD EXCRETION CORRELATED WITH CLINICAL COURSE DURING CHRYSOTHERAPY IN RHEUMATOID-ARTHRITIS

被引：59

作者：

GOTTLIEB, NL

SMITH, EM

SMITH, PM

机构：

来源：

ARTHRITIS AND RHEUMATISM | 1972年 / 15卷 / 06期

关键词：

D O I：

10.1002/art.1780150604

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：582 / &

共 27 条

[1] ADAMS AH, 1950, ANN INTERN MED, V33, P163
[2] [Anonymous], 1960, ANN RHEUM DIS, V19, P95
[3] BAYLES TB, 1956, ANN RHEUM DIS, V15, P394
[4] BLOCK WALTER D., 1940, JOUR BIOL CHEM, V136, P379
[5] BOGG A, 1958, Acta Rheumatol Scand, V4, P86
[6] FISCHEL EE, 1967, LABORATORY DIAGNOSTI, P59
[7] GOLD TREATMENT IN RHEUMATOID ARTHRITIS
FRASER, TN
[J]. ANNALS OF THE RHEUMATIC DISEASES, 1945, 4 (04) : 71 - 75
[8] Metabolism, toxicity and manner of action of gold compounds used in the treatment of arthritis. I. Human plasma and synovial fluid concentration and urinary excretion of gold during and following treatment with gold sodium thiomalate, gold sodium thiosulfate, and colloidal gold sulfide
Freyberg, RH
Block, WD
Levey, S
[J]. JOURNAL OF CLINICAL INVESTIGATION, 1941, 20 (04) : 401 - 412
[9] FREYBERG RH, 1966, ARTHRITIS ALLIED CON, P302
[10] FREYBERG RH, 1942, CLINICS, V1, P537